Skip to main content
Premium Trial:

Request an Annual Quote

BioDiscovery, Exiqon Ink Deal to Sell miRNA Analysis Package

Premium

BioDiscovery and Exiqon announced this week a deal to package BioDiscovery's array image-analysis software with Exiqon's microRNA arrays.

"The partnership … provides a complete well integrated solution for microRNA array studies, going from array experiment with Exiqon's miRcury LNA microRNA arrays to final results with data analysis and visualization from BioDiscovery software," BioDiscovery President Soheil Shams said in a statement.

Financial terms of the arrangement were not disclosed.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.